These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 7763426)
21. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes. Hengstler JG; Bolt HM Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968 [No Abstract] [Full Text] [Related]
22. [P-450 cytochromes and mono-oxygenases. Mechanism of action. Consequences in pharmacology and toxicology (author's transl)]. Mansuy D Ann Biol Clin (Paris); 1980; 38(1):19-23. PubMed ID: 7377646 [TBL] [Abstract][Full Text] [Related]
23. [Induction and inhibition of drug-metabolizing enzymes. Significance for pharmacotherapy, toxicity and clinical testing]. Rugstad HE Tidsskr Nor Laegeforen; 1969 Feb; 89(3):172-6. PubMed ID: 5795436 [No Abstract] [Full Text] [Related]
24. [Problems of drug research]. Büchi J Pharm Weekbl; 1968 Apr; 103(17):429-52. PubMed ID: 4874723 [No Abstract] [Full Text] [Related]
25. [What do we know about the drug metabolism?]. Pelkonen O; Raunio H Duodecim; 1998; 114(10):971-7. PubMed ID: 11524785 [No Abstract] [Full Text] [Related]
26. [Features of the metabolism of various drugs involving cytochrome P-450 isoenzymes]. Filimonova AA; Ziganshin AU; Ziganshina LE Eksp Klin Farmakol; 2007; 70(3):69-77. PubMed ID: 17650639 [TBL] [Abstract][Full Text] [Related]
27. [Metabolism marketing]. Heinzl S Med Monatsschr Pharm; 2004 Aug; 27(8):253. PubMed ID: 15382447 [No Abstract] [Full Text] [Related]
28. Interactions of drug metabolites with hepatic cytochrome P-450. Some implications for drug metabolism. Bast A Pharm Weekbl Sci; 1982 Aug; 4(4):113-4. PubMed ID: 7133961 [No Abstract] [Full Text] [Related]
30. An integrated, multidisciplinary approach for drug safety assessment. Li AP Drug Discov Today; 2004 Aug; 9(16):687-93. PubMed ID: 15341779 [No Abstract] [Full Text] [Related]
33. Considerations of toxicologic interactions in developing new chemicals. Wilkinson CF; Murray M Drug Metab Rev; 1984; 15(5-6):897-917. PubMed ID: 6396059 [No Abstract] [Full Text] [Related]
34. In silico predictive metabolism: a structural/electronic filter method. Harris DL Curr Opin Drug Discov Devel; 2004 Jan; 7(1):43-8. PubMed ID: 14982147 [TBL] [Abstract][Full Text] [Related]
35. Renal drug metabolism. Lohr JW; Willsky GR; Acara MA Pharmacol Rev; 1998 Mar; 50(1):107-41. PubMed ID: 9549760 [No Abstract] [Full Text] [Related]
36. [Study of hepatic drug metabolism. For a rationalization of a new molecular development]. Le Dinh T; Christoforov B Therapie; 1994; 49(2):133-40. PubMed ID: 7817337 [TBL] [Abstract][Full Text] [Related]
37. Prediction of ADMET Properties. Norinder U; Bergström CA ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133 [TBL] [Abstract][Full Text] [Related]
38. The development of drug metabolism research as expressed in the publications of ASPET: Part 3, 1984-2008. Murphy PJ Drug Metab Dispos; 2008 Oct; 36(10):1977-82. PubMed ID: 18635745 [TBL] [Abstract][Full Text] [Related]
39. Biotransformation of drugs in human skin. Svensson CK Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027 [TBL] [Abstract][Full Text] [Related]
40. Drug metabolism and pharmacokinetics in drug discovery. Roberts SA Curr Opin Drug Discov Devel; 2003 Jan; 6(1):66-80. PubMed ID: 12613278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]